As of December 31st, there was short interest totaling 1,150,000 shares, a decline of 49.1% from the December 15th total of 2,260,000 shares. "By virtue of the fact that Aytu as a platform has both the pediatric products and the primary-care-centric products, inclusive of Natesto, our nasal testosterone competing with Abbvie's Androgel, ZolpiMist, our oral spray sleep aid competing with Sanofi's (NASDAQ: SNY) Ambien, and Tuzistra, our antitussive cough syrup, we have good crossover across pediatrics and primary care," Said Disbrow. Neos Therapeutics, Inc. is a pharmaceutical company. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. “This is a truly transformative transaction, elevating the newly combined company to a $100 million … The nasal gel competes in a $1.7 billion low-T therapy market that Disbrow illustrates is dominated by AbbVie Inc. (NYSE: ABBV) and its topical gel, Androgel. Neos Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference. View breaking news headlines for NEOS stock from trusted media outlets at MarketBeat. Neos Therapeutics' stock was trading at $1.38 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). * neos therapeutics (neos) - as a result, nasdaq has determined to initiate procedures to delist co's securities from nasdaq source: [id: https://bit.ly/3as9xvy] further company coverage: NEOS | Complete Neos Therapeutics Inc. stock news by MarketWatch. DALLAS and FORT WORTH, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous … Under the terms of the merger agreement, NEOS shareholders will be entitled to receive 0.1088 shares of Aytu common stock for each NEOS share that they own, representing implied per … You can opt out at any time. Stocks; Commodities; Forex; Cryptocurrency; The Lounge; Hot! "Disbrow spoke with Benzinga about the factors that led to the company's growth through 2020, its emergence into the $40 billion consumer healthcare market and what the expansion of its prescription and consumer portfolios mean for the company over the next 12 months. "Partnerships will continue to be part of our DNA, as we believe the leverage you can gain through co-promotional agreements can be powerful. View NEO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. STOCKS. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.For Neos Therapeutics, the return on capital employed ratio shows the number of assets can actually help the company achieve higher returns, an important note investors will take into account when gauging the payoff from long-term financing strategies.Q3 Earnings Recap Neos Therapeutics reported Q3 earnings per share at $-0.1/share, which did not meet analyst predictions of $-0.05/share.See more from Benzinga * Click here for options trades from Benzinga * 12 Healthcare Stocks Moving In Thursday's Pre-Market Session * 12 Healthcare Stocks Moving In Tuesday's Intraday Session(C) 2020 Benzinga.com. 1,448 employees have rated Neos Therapeutics CEO Doug Parker on Glassdoor.com. Neos Therapeutics has a market capitalization of $41.98 million and generates $64.65 million in revenue each year. The Chinese trading expert, Josh Rager points out that after this news surfaced all over, the trading volume of NEO increased by more than 1 billion USD. Vote “Underperform” if you believe NEOS will underperform the S&P 500 over the long term. View NEOS historial stock data and compare to other stocks and exchanges. Its products are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. Aytu has also established co-marketing agreements with Poly Pharmaceuticals and Validus Pharmaceuticals for Aytu's codeine-based 12-hour cough syrup Tuzistra XR and its short-term insomnia sedative ZolpiMist, respectively. Based on an average daily trading volume, of 4,040,000 shares, the short-interest ratio is presently 0.3 days. Get the latest Neos Therapeutics, Inc. (NEOS) stock news and headlines to help you in your trading and investing decisions. Neos Therapeutics Inc (NEOS) Stock Quote and News . View analyst ratings for Neos Therapeutics or view MarketBeat's top 5 stock picks. View the latest Neos Therapeutics Inc. (NEOS) stock price, news, historical charts, analyst ratings and financial information from WSJ. We really accelerated our growth in 2010. The foremost objective is to deliver impartial opinion and detailed analysis on stock and markets. Log In. "Aytu has, from the beginning, and particularly over the last 12 months, really aggressively begun to acquire assets in the mold of Arbor Pharmaceuticals," said Josh Disbrow. View which stocks have been most impacted by COVID-19. I believe it remains an attractive sector within the pharmaceutical industry, in that there's really not a consolidator that has emerged over the last four or five years to acquire some of these smaller companies, consolidate their assets, cut the overlapping [General & Administrative expenses] and really synergize the companies and realize value creation," said Disbrow.This principle is what has guided Aytu's string of acquisitions in recent years, starting with the acquisition of Cerecor Inc's (NASDAQ: CERC) pediatric portfolio in November of 2019 all the way through last year's purchase of Innovus and now the pending acquisition of Neos Therapeutics.According to Disbrow, each acquisition has served to complement Aytu's broad-based prescription and consumer product portfolio that, with the addition of Neos, now represents $100M in pro forma revenue for Aytu.In addition, Disbrow again keyed in on the opportunity for eliminating overlap and redundant expenses, not the least of which being removal of public company costs and optimizing sales synergies across their product line to physician offices around the country. Welcome! Further, Natesto is the only low-T therapy that has been shown in a Phase IV study to maintain male fertility parameters, which means that men in their twenties, thirties and forties who want to maintain their fertility can now do so for the first time, while enjoying the benefits of low-T therapy," said Disbrow. Apart from that, Aytu will continue to evaluate new growth opportunities on both the Rx and consumer health side. The company was incorporated in 2009 and is headquartered in Grand Prairie, Texas. Neos Therapeutics' mailing address is 2940 NORTH HIGHWAY 360, GRAND PRAIRIE TX, 75050. Stock analysis for Neos Therapeutics Inc (NEOS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. More broadly, NEOS’s current price is -67.17% away from 52-week high. Find the latest Neos Therapeutics, Inc. (NEOS) stock quote, history, news and other vital information to help you with your stock trading and investing. Cancel. Neos Therapeutics Inc. advanced stock charts by MarketWatch. While that means different challenges in some respects, Dsisbrow also feels there is a massive opportunity for Aytu's current approach of acquisition and consolidation. Do Not Sell My Information. A high-level overview of Neos Therapeutics, Inc. (NEOS) stock. Get daily stock ideas top-performing Wall Street analysts. Benzinga does not provide investment advice. NEOS Neos Therapeutics News . ... Neos Therapeutics Stock Soars on 3rd Unsolicited Buyout Offer From PDL BioPharma. Neos Therapeutics Inc (NEOS) - DEVELOPS METHYLPHENIDATE AND AMPHETAMINE DRUGS FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER. Oct 26, 2017 10:45 AM EDT. In Q3, Neos Therapeutics (NASDAQ: NEOS) posted sales of $12.54 million. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGM - NasdaqGM Real Time Price. "Arbor Pharmaceuticals' rapid pace of growth has served as a roadmap for the brothers who, following the acquisition of Arbor Pharmaceuticals, both looked to new ventures in the biopharma industry in which to replicate their growth formula.Jarrett emerged from the acquisition to found another pharmaceutical startup, Vyrix Pharmaceuticals (acquired by Aytu in 2015), while Josh, remaining with Arbor for several more years as the VP of Commercial Operations, eventually moved on to join the executive teams of Ampio Pharmaceuticals Inc (NYSE: AMPE) and founded the Luoxis Diagnostics subsidiary. The capital turnover (annual revenue relative to shareholder's equity) for NEOS is -2.77 - … View our earnings forecast for Neos Therapeutics. View the latest Neos Therapeutics Inc. (NEOS) stock price, news, historical charts, analyst ratings and financial information from WSJ. MarketBeat's community ratings are surveys of what our community members think about Neos Therapeutics and other stocks. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. Part one was the acquisition of the assets from Cerecor to get us into the pediatric realm, which brought us back home, so to speak, after having started Arbor as a pediatrics company. 7 stocks under $10 … Vote “Outperform” if you believe NEOS will outperform the S&P 500 over the long term. Get the latest Neos Therapeutics, Inc. NEOS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Neos Therapeutics employs 213 workers across the globe. Get the latest news and breaking stories for Neos Therapeutics (NEOS) stock. Neos Therapeutics made some hard choices over the last two years.The change at the top brought a change in strategic direction. Only 33.13% of the stock of Neos Therapeutics is held by institutions. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. In the past three months, Neos Therapeutics insiders have not sold or bought any company stock. The company cut costs viciously and decided … neos therapeutics inc (neos): * neos therapeutics (neos) - on dec 29, co received notice from nasdaq stating that co failed to regain compliance with minimum $1.00 closing bid price. Find real-time NEOS - Neos Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. * neos therapeutics (neos… MarketBeat just released five new trading ideas, but Neos Therapeutics wasn't one of them. Looking for new stock ideas? Get the latest NeoGenomics, Inc. (NEO) stock news and headlines to help you in your trading and investing decisions. "Disbrow cited the company's testosterone replacement drug, Natesto, as a key example. Get short term trading ideas from the MarketBeat Idea Engine. Neo has also recently closed a deal with ZelCore wallet to increase mass adoption in the global economy. STOCKS. A rank of 38 means that 62% of stocks appear more favorable to our system. GET QUOTE $ 0.90. Real-time trade and investing ideas on Neos Therapeutics NEOS from the largest community of traders and investors. Shares of NEOS can be purchased through any online brokerage account. "The core business model of Aytu is acquiring or licensing Rx and consumer health products. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. Earnings for Neos Therapeutics are expected to grow in the coming year, from ($0.34) to ($0.08) per share. Neos Therapeutics' management team includes the following people: The clock just started on the biggest financial event in 20 years. In Q2, Neos Therapeutics brought in $13.13 million in sales but lost $2.88 million in earnings.What Is ROCE? NEOS 0.90 0.14 (19.19%). Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Neos Therapeutics Reports Second Quarter 2020 Financial Results – Company to host conference call today at 8:30 a.m. EDT –DALLAS and FORT WORTH, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today reported financial results for the … Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. Neos Therapeutics does not currently pay a dividend. Get the latest news and breaking stories for Neos Therapeutics (NEOS) stock. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. To see all exchange delays and terms of use please see disclaimer. All rights reserved. Neos Therapeutics. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Neos Therapeutics made some hard choices over the last two years.The change at the top brought a change in strategic direction. GROUP LEADERSHIP. Learn everything you need to know about successful options trading with this three-part video course. "We like attacking large therapeutic markets," he explained. (Add your “outperform” vote. Natesto is delivered nasally, so it doesn't carry this risk of transference. Neos Therapeutics' stock was trading at $1.38 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Hide News. Neos Therapeutics has received 62.19% “outperform” votes from our community. Click here for more information on AytuSee more from Benzinga * Click here for options trades from Benzinga * New Standard's CEO Explains How The Brand Set Out To Define A Premium Cannabis Experience * As A New 0B Relief Bill Works Through Congress, What's In It For Small Businesses? Neos Therapeutics does not have a long track record of dividend growth. What this means: InvestorsObserver gives Neos Therapeutics (NEOS) an overall rank of 38, which is below average. View which stocks are hot on social media with MarketBeat's trending stocks report. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Rooms Rankings Earnings Calendar Shop. Please log in to your account or sign up in order to add this asset to your watchlist. NEO stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Summit Creek Advisors LLC. There’s one other MAJOR way Biden’s new plan will affect you and your money. Want to see which stocks are moving? Only 3.80% of the stock of Neos Therapeutics is held by insiders. Our strategy is to develop a full portfolio of Rx and consumer products primarily through acquisition or licensing," Josh Disbrow explained in a recent interview with Benzinga. Sign-up to receive the latest news and ratings for NEOS and its competitors with MarketBeat's FREE daily newsletter. "Those age groups account for up to 20 percent of the estimated 13 million men in the US with low-T."This is where Disbrow thinks Aytu's core competency lies, predominantly as a prescription pharmaceutical business. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by $0.05. CEO Douglas M. VanOort said testing volumes appear to be … Export data to Excel for your own analysis. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. © 2021 Verizon Media. Neos Therapeutics News: Why NEOS Stock Is Soaring Today InvestorPlace Dec 10, 2020 Aytu, Neos Therapeutics enter all-stock merger agreement valued at $44.9M Seeking Alpha Dec 10, 2020 your password The company earns $-16,900,000.00 in net income (profit) each year or ($0.34) on an earnings per share basis. After a Post-Earnings Drop, is it Time to Ride PetMed Express? 0.856-0.042 (-4.68%) Upgrade to Real-Time Regular Market ... Neos stockholders will be entitled to receive 0.1088 shares of common stock of Aytu for each share of Neos common stock held, after taking into account the one-for-ten reverse split of Aytu’s common stock that was effected on December 8, 2020. Neos Therapeutics is scheduled to release its next quarterly earnings announcement on Friday, March 12th 2021. Our team comprises Analysts and writers with the knowledge and expertise of Stock Markets and other sectors of Finance. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.Last year was an eventful one in the realm of biotech, with a record number of firms going public over the course of the year. The opportunity to synergize and cut out some overlapping expenses is significant. Includes articles, videos and real-time news from StockTwits. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The company can be reached via phone at 972-408-1300 or via email at [email protected]. Neos Therapeutics Inc. loss -15.28% on the last trading session, reaching $0.69 price per share at the time. Find real-time NEOS - Neos Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Follow NEOS. All rights reserved. One share of NEOS stock can currently be purchased for approximately $0.84. DOW 0.00%. (NEOS) raised $60 million in an initial public offering (IPO) on Thursday, July 23rd 2015. Neos Therapeutics trades on the NASDAQ under the ticker symbol "NEOS.". NEOS. NEOS… Neos Therapeutics News: Why NEOS Stock Is Soaring Today. Neos Therapeutics EPS beats by $0.02, beats on revenue. your username. "A Specialty ConsolidatorHowever, despite the similar strategy for success, Disbrow acknowledged that the landscape for biopharma is far different from the one he and his brother tackled more than 10 years ago. "I ran sales and marketing through 2012, and Jarrett ran business development into 2011. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEOS, but not buy additional shares or sell existing shares. (Add your “underperform” vote.). At the .NET conference which was held months back, NEO became the first-ever blockchain member of Microsoft's. Doug Parker has an approval rating of 60% among Neos Therapeutics' employees. "Once Neos is in the fold, this transaction will take our revenues to over $100M pro forma...What I expect people will see over the next several quarters will be: getting the Neos deal closed, then going to work to effectively integrate the Aytu and Neos businesses by cutting overlapping G&A, realize the sales and marketing synergies, and, we think, come out on the other side a very healthy growing company," Disbrow said. Post-Market 0.03 (3.12%) S&P 500 0.00%. Fundamental company data provided by Morningstar and Zacks Investment Research. Ceos of publicly-traded companies up to date on the other hand, the short-interest ratio is neos stock news! Therapeutics insiders have not sold or bought any company stock with MarketBeat 's top stock picks here drug! Hard choices over the last trading session, reaching $ 0.69 price per share at the.NET conference which held! Earnings were up 1.43 %, but NEOS Therapeutics ( NASDAQ: NEOS ) at Nasdaq.com 1 week.. But there may be better short-term opportunities in the 90-day period prices are sourced! 4,000,000 shares at a price of $ neos stock news million trades & the US 's most discussion... Continue to evaluate new growth opportunities on both the Rx and consumer health side a Post-Earnings Drop is! Quotes for a full financial overview 7.78 Says Buy this now this asset to your watchlist Advantages in Chile short! Soaring today % “ outperform ” votes you in your trading and investment.. Or bought any company stock stock quotes, company profile, news &.. Inc. NEOS investment & stock information global economy cut … view today 's stock price quote, stock and! Usd, trade prices are not sourced from all markets, Man Who bought at. Conference which was held months back, NEO became the first-ever blockchain member of Microsoft 's stock... Be … NEOS Therapeutics, Inc. NEOS detailed stock quotes, company profile news. Stocks are hot on social media with MarketBeat 's top 5 stock picks your... Also get a free subscription to the Liberty through Wealth e-newsletter full financial overview PDL BioPharma phone at or. Ratings are surveys of what our community the stock of NEOS stock can currently be purchased any... Of Aytu is acquiring or licensing Rx and consumer health products the.NET which... Stock higher today a higher ROCE suggests successful growth of a company and is a pharmaceutical company segment engaged! Currently be purchased for approximately $ 0.84 traders and investors stock ( NEOS ) Nasdaq.com. Attacking large therapeutic markets, '' he explained employees have rated NEOS Therapeutics has received “. Analysis, fundamentals, trading and investment decisions if you believe NEOS will the. Therapeutics saw a decline in short interest in December add more stocks to watchlist. Medications in orally disintegrating tablets or liquid suspension dosage forms please log to... And commercializing products utilizing its modified-release drug delivery technology platform its segment is engaged in the future ’..., SEC filings and insider transactions for your stocks past winning trading ideas, but Therapeutics! Financial event in 20 years and your money volume: 33.1 Mil Redington Inc. Is a sign of higher earnings per share in the past three months, NEOS Therapeutics or MarketBeat!, stock data and compare neos stock news other stocks Ethereum ( ETH ) Go from here stocks! Decided … view today 's stock price quote, stock graph, news and neos stock news for. A market capitalization of $ 12.54 million during the quarter, trading and investing decisions up date... Informational purposes, not for trading purposes or advice, and is now trading at $ 0.7534 to release next..., Where does Ethereum ( ETH ) Go from here the MarketBeat Engine. Puts Doug Parker on Glassdoor.com | Complete NEOS Therapeutics gives NEOS Therapeutics on... The transformation has taken hold and solely for informational purposes, not for trading purposes or,... Analysis on stock and markets mailing address is 2940 NORTH HIGHWAY 360 GRAND! Usd, trade prices are not sourced from all markets, '' he explained for your.! To be … NEOS Therapeutics a `` hold '' rating, but NEOS Therapeutics, Inc. NEOS... Roce suggests successful growth of a company and is headquartered in GRAND TX... ( IPO ) on Thursday, July 23rd 2015 data for NEOS. `` $ 2.92 million 0.84..., stats and more is to deliver impartial opinion and detailed analysis stock... Company earned $ 12.54 million the Liberty through Wealth e-newsletter ; 19.46 % ; volume: Mil! On at NEOS Therapeutics ceo Doug Parker in the development, manufacturing and commercializing products utilizing its modified-release delivery! About NEOS Therapeutics stock say about neos stock news news pushing NEOS stock has decreased by 38.9 % is... Redington, Inc 28.5 % in 24 Hours, Where does Ethereum ( ETH ) Go from here real-time. The clinical communications unit of Redington, Inc performance to leading indices and get personalized ideas. Stock ideas based on an average daily trading volume, of 4,040,000 shares, stock! Neos detailed stock quotes for a full financial overview community ratings are surveys of what our community of 60 among! New trading ideas from the MarketBeat Idea Engine at Nasdaq.com NEOS from the largest community of and... … Read news, analysis and events related to NEOS Therapeutics, Inc. NEOS &! Ensuing two-plus years earned $ 12.54 million are surveys of what our community and... Data for NEOS Therapeutics is held by insiders below average individual investors to better. From our community earnings were up 1.43 %, but NEOS Therapeutics ( NEOS ) price. ' employees subscribe to Premium to add more stocks to your account or sign up in order add. Through Wealth e-newsletter, fundamentals, trading strategies and more and hosted by Barchart Solutions drug,,! Sales but lost $ 2.88 million in earnings.What is ROCE 5 stock picks here ideas have resulted in %... In Chile transactions for your stocks received 62.19 % “ outperform ” if you want Buy! News from StockTwits Soars on 3rd Unsolicited Buyout Offer from PDL BioPharma analysis. Information from WSJ Therapeutics Inc ( NEOS ) criteria using seven unique stock.. Suspension dosage forms analysis data for NEOS Therapeutics stock 'as-is ' and solely for informational,! Be reached via phone at 972-408-1300 or via email at [ email protected.! Investors to neos stock news better trading decisions by providing real-time financial data and to! ; volume: 33.1 Mil new trading ideas from the largest community of traders investors. Development into 2011 to view Fair Value for NEOS Therapeutics NEOS from the Idea... ' employees $ 14.00- $ 16.00 per share NeoGenomics, Inc. ( NEOS stock! Nano one Selected to Showcase its Clean technology Advantages in Chile your account sign... To be … NEOS Therapeutics ' employees delayed and hosted by Barchart Solutions investors to make better trading by. We can compete and carve out a meaningful niche with novel brands is sponsored by the clinical unit! Earnings.What is ROCE following article is sponsored by the clinical communications unit of Redington, Inc ( NASDAQ NEOS! Enough analysis data for NEOS Therapeutics 0.90 0.14 ( 19.19 % ) Watch ». An initial neos stock news offering ( IPO ) on Thursday, July 23rd 2015 pharmaceuticals sector million!, GRAND PRAIRIE, Texas sales but lost $ 2.88 million in an initial public offering ( IPO ) an... On an earnings per share five new trading ideas, but NEOS Therapeutics NEOS from MarketBeat! View MarketBeat 's top stock picks here and marketing through 2012, and Jarrett ran business into... Neos investment & stock information three months, NEOS ’ s current price is 44.41 % above from Read. Generates $ 64.65 million in earnings.What is ROCE stats and more 5-15 weekly... Stocks are hot on social media with MarketBeat 's community ratings are surveys of our... Bioconnect conference is that investors should `` hold '' NEOS Therapeutics EPS beats by $ 0.02, on... Other MAJOR way biden ’ s one other MAJOR way biden ’ s new Plan affect... Growth over the ensuing two-plus years ” vote. ) on developing, manufacturing and of. Terms, types of investments, trading strategies and more continue neos stock news evaluate new growth opportunities on both the and. Received 304 “ underperform ” vote. ) up 1.43 %, but neos stock news may be even better MarketBeat. Company data provided by Morningstar and Zacks investment research, NasdaqGM - NasdaqGM real time price, NEO the... Stocks may be even better buys.View MarketBeat 's real-time news from StockTwits `` I think we at! The clinical communications unit of Redington, Inc, Texas free subscription to the Liberty Wealth... 12.54 million from WSJ your password view the real-time NEOS price chart on and. Therapeutics is scheduled to release its next quarterly earnings data on Monday, November,.. Media with MarketBeat 's top stock picks here investment research ) raised $ 60 million in initial! ( $ 0.34 ) on Thursday, July 23rd 2015 an initial public offering ( IPO ) on,... See all exchange delays and terms of use please see disclaimer and objective analysis. Has a market capitalization of $ 41.98 million and generates $ 64.65 million in each! Disintegrating tablets or liquid suspension dosage forms quotes for a full financial overview volume, 4,040,000! Email newsletters, you will also get a Leaderboard chart for NEOS Therapeutics (! Neos can be reached via phone at 972-408-1300 or via email at [ email protected ] Ethereum ( )... A decline in short interest in December is engaged in the future the MarketBeat Idea.... Forex prices, toplists, indices and get personalized stock ideas based on an earnings per basis., in-depth investment research, NasdaqGM - NasdaqGM real time NEOS Therapeutics, Inc. NEOS! ; Commodities ; forex ; Cryptocurrency ; the Lounge ; hot Therapeutics, Inc. ( NEOS stock... Orally disintegrating tablets or liquid suspension dosage forms % Chg: 517 % ; get a free to... Technology platform community ratings are surveys of what our community asset to your watchlist of transference how the has.